It's time for our end-of-year round up of highlights from @lancetgastrohep.bsky.social! www.linkedin.com/posts/langas... #GastroSky #MedSky #LiverSky #IDSky #EndoSky

Say it louder for those at the back… #NOhep

New Editorial - ACIP’s HBV birth-dose vaccine recommendations: a fiasco www.thelancet.com/journals/lan... #HepSky #LiverSky #MedSky #IDSky

🆕 The first published Comments in The Lancet Regional Health - Africa are now available online! Topics include cholera, global health architecture, Ebola, & artificial intelligence. Read the Comments & find out more about the new journal: spkl.io/63329AgQkW

Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial spkl.io/63325AgSD7

Our January 2026 issue is out now: www.thelancet.com/gastrohep Content includes #MASH, #IBD, #PBC, #PSC, #ageing, #diet + more! #GastroSky #MedSky #IBDSky

New Review Best practice guidelines for viral hepatitis service delivery in prisons www.thelancet.com/journals/lan...

New research - Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial www.thelancet.com/journals/lan... #OncSky #GastroSky @oncoalert.bsky.social rt

New research - Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12Cmutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials www.thelancet.com/journals/lan... #GastroSky #OncSky #MedSky

New research - Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial www.thelancet.com/journals/lan... #GastroSky #LiverSky #OncSky #MedSky

New Comment - Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel disease www.thelancet.com/journals/lan... #GastroSky #MedSky #IBDSky

🚨Our Dec issue is live! - thelancet.com/issue/S1470-... 📊Articles: #lungcancer, #breastcancer, #hepatocellularcarcinoma, #rectalcancer, #glioma 📑Reviews including neurocognitive outcomes in patients with brain metastases AND SISAQOL-IMI consensus guidelines on PROs in trials

New research - Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial www.thelancet.com/journals/lan... #GastroSky #MedSky #IBDSky

New research @eClinicalMed - A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities www.thelancet.com/journals/ecl... #GastroSky #MedSky #IBDSky

New @eclinicalmed.bsky.social - Preprocedural screening for multidrug-resistant organisms in endoscopic retrograde cholangiopancreatography: an international, multicentre, cross-sectional observational study www.thelancet.com/journals/ecl... #GastroSky #MedSky #IDSky #MicroSky

New @eClinicalMed - Effects of glucagon-like peptide-1 receptor agonists on alcohol consumption: a systematic review and meta-analysis www.thelancet.com/journals/ecl... #GastroSky #MedSky #EndoSky

New at The Lancet Digital Health - Development and validation of a machine-learning model to reduce futile procurements in donations after circulatory death in liver transplantation in the USA: a multicentre study www.thelancet.com/journals/lan... #LiverSky #MedSky

Despite their high prevalence, alcohol use disorders remain undertreated. A recent Seminar discusses the need for integrated alcohol control policies to improve the prevention of alcohol use disorders, improve access to treatment, and reduce stigma: spkl.io/63324Abjiu

Liver cancer is the 6th most common cancer globally. Join our webinar exploring The Lancet's Commission on addressing the global liver cancer burden and its comprehensive strategies from prevention to treatment. 👉 Register: hubs.li/Q03GK-q50 #oncology #hepatology #lgcw2025

📣 Big news! We’re excited to announce the Advisory Board for The #LancetSummit: shaping the future of #diabetes prevention. Welcome Amanda Adler, Kamlesh Khunti, Dianna Magliano, Chantal Mathieu and Didac Mauricio Puente. Find out more and submit your abstract to join the Summit: hubs.li/Q03MV20T0

🔔 Introducing The Lancet Regional Health – Africa, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in Africa. Explore the new journal: ➡️ spkl.io/63325AbmLD#goldopenaccess#MedSky

New @thelancet.com - Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study www.thelancet.com/journals/lan... #LiverSky #MedSky #EndoSky

Our November issue is now online: www.thelancet.com/journals/lan... Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #HTLV-1 #AMR #Lassa #Neisseria #gonorrhoea #tuberculosis #TB #influenza #IDSky #ClinMicro #OA

Endometriosis affects around 190 million women and girls globally. Despite progress, the exact causes remain unknown. The latest issue of @lancetobgyn-wh.bsky.social features articles on advancements & the research still needed. 🔗 : tinyurl.com/4by2evfs

NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm Plus, linked Comment bit.ly/4hOOOmz #Medsky #Rheumsky

Our December issue is out now at www.thelancet.com/journals/lan... Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more! #GastroSky #LiverSky #MedSky

What if we could work together to change the future of liver cancer? Join our webinar exploring how we can tackle the rising trend of liver cancer and differences in disease management across regions, hosted as part of London Global Cancer Week. 📆 Nov 27, 9am GMT 👉 Register: hubs.li/Q03GK-q50

Non-coeliac gluten sensitivity (NCGS) remains a highly debated condition, despite ~10% of the global population self-reporting a gluten or wheat sensitivity. A new Review examines current evidence & provides practical guidance for assessment and management: tinyurl.com/yjafmhc5

🚨Our Nov issue is live - thelancet.com/issue/S1470-... 📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)

New research - Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial www.thelancet.com/journals/lan... #LiverSky #MedSky

New research - Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial www.thelancet.com/journals/lan... #LiverSky #MedSky

New research - Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study www.thelancet.com/journals/lan... #GastroSky #MedSky

Our November issue is live! Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

New Review - Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver Diseases www.thelancet.com/journals/lan... #LiverSky #MedSky

New research - Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial www.thelancet.com/journals/lan... #GastroSky #MedSky #OncSky

Alcohol use disorders remain a major public health problem globally. A new Seminar discusses the need for integrated alcohol control policies to improve the prevention of alcohol use disorders, improve access to treatment, and reduce stigma: tinyurl.com/395uf8f5

New research article Evaluation of bacteriophages as a signature of #microbiome health: a systematic review and meta-analysis www.thelancet.com/journals/lan... #IDSky #ClinMicro #ViroSky #Phage #OpenAccess #OA

Our October issue is now live! Includes our Series on transforming mental health in Europe, plus Articles on tuberculosis, intrahepatic cholangiocarcinoma, asthma, hip fracture, frontotemporal dementia, liposarcoma, cerebral cavernous malformations, and much more 👇 www.thelancet.com/issue/S2666-...

Our October issue is now online: www.thelancet.com/journals/lan... Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #Trypanosoma #Chagas #Streptococcus #AMR #gonorrhoea #cytomegalovirus #cholera #mpox #TB #IDSky #ClinMicro #OA

There is substantial heterogeneity in the contributors to the pathophysiology of #MASLD, which might influence its rate of progression, its relationship with #cardiometabolic diseases, and the response to therapy www.thelancet.com/journals/lan... #OpenAccess #MedSky #EndoSky #LiverSky #HepSky

Read our November Issue, featuring glucocorticoid-induced osteoporosis, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, type 1 diabetes, medical education, older adults, & much more tinyurl.com/mwfu4c6m #MedSky #EndoSky #RheumSky

New review - Age-related changes of the gastrointestinal tract www.thelancet.com/journals/lan... #GastroSky #MedSky

Most up-to-date evidence suggests several behavioural therapies are effective at treating irritable bowel syndrome (IBS), but stronger evidence is needed. Find out more in @lancetgastrohep.bsky.social: tinyurl.com/2r4hvz3x

The October 2025 issue of The Lancet Regional Health - Americas is now available online: lnkd.in/gn2YTxQW In this issue, we covered #Malaria; #ColorectalCancer; #ChagasDisease; #CognitiveHealth; #TobaccoPolicy; #SickleCell; #ObesityDiagnosis; #HealthCareResilience; and much more.

New research - Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis www.thelancet.com/journals/lan... #GastroSky #MedSky @alexanderford25.bsky.social @romegastropsych.bsky.social

Our latest issue is out now at www.thelancet.com/gastrohep! Content includes #obesity, #MASLD, #FMT for #Cdiff #viralhepatitis, #cirrhosis, #DGBI & more! #GastroSky #LiverSky #MedSky

Opening plenary time at #UEGWeek! The first research of the session is presented by Yorick van de Pavert, with the ENDURO trial of endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction #GastroSky #MedSky

Let’s go… #UEGWeek #GastroSky #MedSky

🚨Our Oct issue is live - thelancet.com/issue/S1470-... 📈Articles: on #RCC, #SCLC, #NSCLC, #BladderCancer, #Myeloma, #PancreaticCancer, #EndometrialCancer, and #ThyroidCancer 📝Reviews: EU–CAYAS–NET recommendations for health-care transitions in young people beyond childhood cancer

🔔 Introducing The Lancet Regional Health – Africa, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in Africa. Explore the new journal at hubs.li/Q03KzMp00 #MedSky